ABSTRACT: Nonesterified fatty acids (NEFA) are measured routinely in the study of nutrition and growth physiology. To improve the efficiency with which this variable is measured, a two-reaction, enzymatic-based assay was adapted and validated to quantify NEFA in bovine blood plasma using 96-well microtiter plates. The effects of incubation time, temperature, and of sample volume were examined in addition to possible interfering substances, recovery, reagent stability, and range of linearity. Incubation for 30 min at 21°C for each of the two reactions resulted in maximal slope and r2 values (1.94 and .999, respectively). Percentage of recovery was 107% when using 5 pL and 100% when using 10 pL of heparinized bovine plasma in the assay. Uniform linear standard curves ( r 2 > .99) were obtained using reagents stored at 4°C for 9 d. An equal volume of 1 mM acetate, propionate, valerate, and butyrate added to plasma did not affect results. The assay was linear from 125 t o > 1,000 pEq/L. Intra-and interassay CV for the 5-pL sample volume were 3.6 and 3.7%, respectively. This modified assay provides results comparable to the standard assay yet reduces reagent and labor requirements and increases sample capacity.
Introduction
The concentration of nonesterified fatty acids (NEFA) in plasma is an indicator of lipid mobilization and, therefore, is of interest to researchers of nutrition and growth physiology. An accurate and precise enzymatic method is available commercially as a kit ( NEFA-C Wako Chemicals USA, Richmond, VA). Our objective was to adapt this procedure for use in a 96-well microtiter plate system to increase sample throughput and decrease the cost of labor and supplies. The factors examined were sample and reagent volume, incubation time, possible effects due to VFA, and reagent and sample stability.
Materials and Methods
Assay. The principle of the assay is as follows:
NEFA, in the presence of ATP, coenzyme A ( CoA), and acyl-CoA synthetase, forms acyl-CoA and the byproducts AMP and pyrophosphate. Then, the prodlTo whom correspondence should be addressed. Present address: A. L. Laboratories, Inc., One Executive Dr., P.O. Box 1399, Fort Lee, NJ 07024.
Received June 4, 1992. Accepted October 1, 1992. uct acyl-CoA is oxidized by acyl-CoA oxidase, which produces hydrogen peroxide (and 2,3 trans-enoylCoA). Peroxidase acts on the hydrogen peroxide in the presence of 3-methyl-N-ethyl-N-(/3-hydroxyethyl)-aniline and 4-aminoantipyrine to form the final reaction product, a purple quinone ( Y~~, 550 nm).
Reagents. Provided with the NEFA-C lut are 1)
Color Reagent A (acyl-CoA synthetase, 3 U/vial; ascorbate oxidase, 30 U/vial; coenzyme A, 7 mg/vial; ATP, 30 mg/vial; 4-aminoantipyrine7 3 mg/vial), 2) Color Reagent A diluent (contains phosphate buffer, pH 6.9, 50 mM; magnesium chloride, 3 mM; surfactant, stabilizers), 3) Color Reagent B vial (acyl-CoA oxidase, 132 Uhial; peroxidase, 150 U/vial), 4) Color Reagent B diluent (3-methyl-N-ethyl-N-[@-hydroxyethyll-aniline, 1.2 mM; surfactant), and 5) NEFA Standard (oleic acid, 1,000 pEq/L; surfactant; stabilizers). Phosphate buffer (pH 6.9, 50 mM) was prepared. Reagents were prepared according to the modifications described by McCutcheon and Bauman (1986) and Sechen et al. (1990) . Briefly, Color Reagent A was diluted with 10 mL of Color Reagent A diluent, inverted until dissolved, then mixed with 13.3 mL of 50 mM phosphate buffer and stored at 4°C. Color Reagent B was diluted with 20 mL of Color Reagent B diluent, inverted until dissolved, then mixed with 33.3 mL of 50 mM phosphate buffer and stored at 4°C.
Working standards (125, 250, 500, 1,000 pEqiL) were prepared by diluting stock standard with 50 mM phosphate buffer (pH 6.9) and were stored at -20°C.
Assay Procedure. The NEFA were analyzed in a 96-well, flat-bottomed, polystyrene microtiter plate (Corning Glass Works, Corning, NY). A UVMAX Microtiter Plate Reader (UVMAX; Molecular Devices, Palo Alto, CA) was used to shake the microtiter plates and measure absorbance. To each microtiter plate well, 5 pL of sample, standard, or blank (phosphate buffer) was added manually. Immediately following, 95pL of Color Reagent A was added. The reaction mixture was mixed on the UVMAX. The plate was incubated for 30 min at 21"C, after which 195 pL of Color Reagent B was added to each well. The plate was again mixed on the UVMAX and incubated for 30 min at 21°C. The absorbance of the final reaction product was measured at 550 nm on the UVMAX. The volumes of reagent, sample, and the incubation times that were examined are discussed in later sections. Using this microtiter plate assay each kit provides enough reagent to conduct > 1,400 determinations.
Incubation Times. The original assay procedure specifies two separate 37°C incubations, designated A and B, respectively. For the microtiter plate assay a 21°C incubation was used to minimize possible uneven evaporation of the reaction mixture that could occur at higher temperatures. Therefore, it was necessary to optimize both reactions at room temperature.
Nine different incubation A times and six different incubation B times were examined. Replicate microtiter plates were set up as follows: working standard ( 5 pL) plus Color Reagent A (95 pL) were added to each well at the following times: -360, -240, -120, -60, -45, -30, -15, and -5 min. At time 0, reagent B (195 pL) was added to all wells. The absorbance at 550 nm was read at 5 , 15, 30, 45, 60, and 120 min. For each incubation A time, the following standard concentrations were used; 0, 125, 250, 500, 1,000, and 2,000 pEq/L.
Recovery and Parallelism.
To evaluate the accuracy of the assay for measuring increments of NEFA (e.g., recovery), assays were conducted wherein additional NEFA were added to a constant volume of bovine blood plasma. Also, parallelism, an assessment of the robustness of the assay to changes in blood sample volume, was assessed by adding to each well of a NEFA standard curve series either 5, 10, or 15 pL of blood plasma. Working standards of NEFA (5 pL) were added to wells containing various amounts of plasma. Plasma was obtained from three different steers by collecting whole blood into syringes containing heparin (final concentration of 15 IUlmL). Plasma was separated after centrifugation (545 x g) for 15 min at 4°C (Sorvall RT6000B refrigerated centrifuge, DuPont Instruments, Newtown, CT). Plasma was stored immediately at -20°C until it was analyzed. The concentrations of the working NEFA standards were 0, 125, 250, 500, and 1,000 pEq/L and the total well volume was constant at 300 pL, resulting in final LND PETERS standard amounts per well of 0, .625, 1.25, 2.5, and 5.0 nEq. The NEFA were measured in triplicate. Reagent and Sample Stability. The stability of the prepared working reagents was measured by analyzing, in quadruplicate, fresh aliquots of previously frozen working standards over a period of 9 d using reagent prepared on d 1 and stored at 4°C. The volumes used were 5, 95, and 195 pL for working standard, reagent A, and reagent B, respectively.
Effects of Volatile Fatty
To assess stability of NEFA in plasma, heparinized plasma samples from three different steers were used. Aliquots of plasma from each of the three steers were distributed to 2.5-mL microcentrifuge tubes (Evergreen Scientific, Los Angeles, CAI. The effect of repeated freeze-thaw cycles was quantified. The control treatment consisted of holding freshly harvested plasma at 4°C until analysis. Other treatments consisted of exposing other aliquots to either one, two, and three freeze-thaw cycles. Samples were frozen in dry ice, held for 5 min, and then thawed in a water bath at 21°C. Samples were then held for approximately 90 min at 4°C until they were assayed. All tubes were then assayed for NEFA to assess sample stability. All assays were performed in triplicate. Sample size, reagent A, and reagent B volumes were 5, 95, and 195 pL, respectively. Intra-and interassay CV were determined by assaying in duplicate a pooled plasma sample in each of three independent assays. Data Analyses. Data were analyzed using linear regression and analysis of variance procedures. The statistical computations were performed using PROC REG@ and the GLM of procedures of SAS (1985) .
Results
Incubation Times. The nine incubation A (first reaction) and six incubation B (second reaction) times were tested in a 9 x 6 factorial arrangement. Slope, intercept, and r2 values were calculated for each of the 54 incubation time combinations. Slope was used as the summary variable for the statistical analysis (Table 1 ). There was no interaction between time of incubations A and B ( P = 1.000). The duration of reaction A was significant ( P = .0001) although time of incubation B was without effect ( P = .784). For incubation A, times of 5 min and 360 min differed from all other incubation times ( P < .05; Table 1 ). Slopes were numerically greatest at incubation times of 15 to 45 min for both reactions A and B. The r2 and intercept values were similar for all reaction B incubation times and were maximal for reaction A at incubation times > 30 min.
Incubation times of 30 min for both reactions A and B seemed acceptable for achieving greatest sensitivity as supported by the maximal slope and r2 values. All subsequent evaluations were conducted using these incubation times.
Recovery and Parallelism. Measured and predicted
NEFA values, as well as percentage of recoveries, sample size, and CV are given in Table 2 . The percentage of recovery results were consistently higher for the 5-pL than for the 15-pL sample volume. The CV of the 5-pL sample volume size was slightly greater, which may be due to decreased pipetting accuracy of small volumes and to the fact that the NEFA content is lower in the 5-pL volume. The average CV, however, for 5-pL size was only 3.8%. Likewise, the sample volume of 10 pL seemed acceptable. Based on the increased recovery values and on the fact that the average CV for 5 or 10 p L were acceptable, 5 or 10 pL would be acceptable sample volumes for the assay.
Effect o f Volatile Fatty Acids. The observed NEFA concentrations for plasma with and without added VFA standards did not differ. The NEFA concentrations of the plasma samples ranged from 230 to 420 pEq/L. After addition of an equal volume of VFA (1 mM of each of the aforementioned acids), measured concentrations of NEFA were 98.3 f 2.9% ( X k SE) of those measured without added VFA. Therefore, VFA do not seem to be substrates for the reagents used in this assay.
Reagent and Sample Stability. The slope, intercept, and r2 values of the standard curves from 9-d-old reagent (1.85 x lop5, .046, 1.00) were not significantly different from reagent prepared fresh (1.96 x lop5, (sample size (pL)/5 pL)] + nEq/well of standard The microtiter assay described in this report allows NEFA concentrations in bovine plasma to be quantified accurately and reproducibly. After they are prepared, the reagents remain stable for up to 9 d. Samples can be assayed at room temperature and precise timing is not essential for both incubations. The UVMAX equipment facilitates the direct, electronic transfer of data to the mainframe computer for graphical and statistical analysis. Reagents specified to permit 50 determinations per kit can be used to conduct > 1,400 determinations per kit. Rather than requiring 50 pL of plasma, only 5 pL is necessary for each test. Overall, the .procedure is easy to perform and cost-effective and greatly increases sample throughput.
Discussion Implications
The suitability of this assay for bovine blood plasma was determined. The presence of acetic, propionic, butyric, or valeric acids did not affect measurement of the longer-chain NEFA. Of note, however, was our observation that when the assayed volume of plasma was increased the apparent concentration decreased. This result suggests either that a plasma component interferes with the enzymatic reaction or that inadequate reagents, enzymes, or both are present when a 15-pL sample is used. This potential problem is moot in view of 1) the approximately 100% recoveries obtained when using 5-and 10-pL sample volumes and 2) the wide linear range of the assay that eliminates the need to dilute samples. Repeated freezing and thawing did not affect the observed concentrations.
A modified microassay for nonesterified fatty acids has been described and validated for use with bovine blood plasma. Using a microtiter plate format, fiber optic-assisted spectrophotometry, and electronic transfer of data, this procedure permits simple, rapid, and precise measurement of nonesterified fatty acids.
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